{"entity":{"type":"insider","cik":"0001592286","url":"/insider/0001592286","json_url":"/insider/0001592286.json","name":"Wrighton-Smith Peter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":19,"first":"2016-12-05","last":"2020-05-12","span_basis":"filed_date"},"name_variants":[{"name":"Wrighton-Smith Peter","source":"filing","n_filings":19,"first_seen":"2016-12-05","last_seen":"2020-05-12"}],"transactions":[{"id":3101659,"accession":"0001437749-20-010441","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-20-010441","line_url":"/filing/0001437749-20-010441#line-3","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15525.0,"shares_display":"15,525","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":179469.0,"total_display":"179,469.00","total_whole":"179,469","shares_owned_after":400225.0,"shares_owned_after_display":"400,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-12","scope":"insider"},{"id":3101653,"accession":"0001437749-20-010441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-20-010441","line_url":"/filing/0001437749-20-010441#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26000.0,"shares_display":"26,000","price_per_share":11.45,"price_display":"11.45","price_state":"stated","total_value":297700.0,"total_display":"297,700.00","total_whole":"297,700","shares_owned_after":384700.0,"shares_owned_after_display":"384,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-12","scope":"insider"},{"id":3101648,"accession":"0001437749-20-010441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-010441","line_url":"/filing/0001437749-20-010441#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2075.0,"shares_display":"2,075","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":22306.25,"total_display":"22,306.25","total_whole":"22,306","shares_owned_after":358700.0,"shares_owned_after_display":"358,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-12","scope":"insider"},{"id":8683972,"accession":"0001437749-19-019606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-019606","line_url":"/filing/0001437749-19-019606#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":16.2134,"price_display":"16.21","price_state":"stated","total_value":486402.0,"total_display":"486,402.00","total_whole":"486,402","shares_owned_after":294538.0,"shares_owned_after_display":"294,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-01","filed_date":"2019-10-03","scope":"insider"},{"id":7901215,"accession":"0001437749-19-019043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-19-019043","line_url":"/filing/0001437749-19-019043#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":17.0137,"price_display":"17.01","price_state":"stated","total_value":1361096.0,"total_display":"1,361,096.00","total_whole":"1,361,096","shares_owned_after":324538.0,"shares_owned_after_display":"324,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-24","filed_date":"2019-09-25","scope":"insider"},{"id":7901211,"accession":"0001437749-19-019043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-019043","line_url":"/filing/0001437749-19-019043#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.9183,"price_display":"14.92","price_state":"stated","total_value":298366.0,"total_display":"298,366.00","total_whole":"298,366","shares_owned_after":404538.0,"shares_owned_after_display":"404,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-25","scope":"insider"},{"id":7985068,"accession":"0001437749-19-017192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-017192","line_url":"/filing/0001437749-19-017192#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.8647,"price_display":"13.86","price_state":"stated","total_value":138647.0,"total_display":"138,647.00","total_whole":"138,647","shares_owned_after":424538.0,"shares_owned_after_display":"424,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-20","scope":"insider"},{"id":8423765,"accession":"0001437749-19-006477","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-19-006477","line_url":"/filing/0001437749-19-006477","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10600.0,"shares_display":"10,600","price_per_share":16.676581132075473,"price_display":"16.68","price_state":"stated","total_value":176771.76,"total_display":"176,771.76","total_whole":"176,772","shares_owned_after":435138.0,"shares_owned_after_display":"435,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider","n_lines":2},{"id":7984917,"accession":"0001437749-19-002954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-002954","line_url":"/filing/0001437749-19-002954#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.9934,"price_display":"16.99","price_state":"stated","total_value":169934.0,"total_display":"169,934.00","total_whole":"169,934","shares_owned_after":413469.0,"shares_owned_after_display":"413,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-20","scope":"insider"},{"id":7984849,"accession":"0001437749-19-000742","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-000742","line_url":"/filing/0001437749-19-000742#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.9073,"price_display":"14.91","price_state":"stated","total_value":149073.0,"total_display":"149,073.00","total_whole":"149,073","shares_owned_after":423469.0,"shares_owned_after_display":"423,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-10","filed_date":"2019-01-11","scope":"insider"},{"id":6460927,"accession":"0001437749-18-017909","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-18-017909","line_url":"/filing/0001437749-18-017909#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.926,"price_display":"16.93","price_state":"stated","total_value":169260.0,"total_display":"169,260.00","total_whole":"169,260","shares_owned_after":433469.0,"shares_owned_after_display":"433,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-02","filed_date":"2018-10-03","scope":"insider"},{"id":6460925,"accession":"0001437749-18-017909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-18-017909","line_url":"/filing/0001437749-18-017909#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":165000.0,"total_display":"165,000.00","total_whole":"165,000","shares_owned_after":443469.0,"shares_owned_after_display":"443,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-03","scope":"insider"},{"id":6204510,"accession":"0001437749-18-017553","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-18-017553","line_url":"/filing/0001437749-18-017553","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86100.0,"shares_display":"86,100","price_per_share":18.417752380952383,"price_display":"18.42","price_state":"stated","total_value":1585768.48,"total_display":"1,585,768.48","total_whole":"1,585,768","shares_owned_after":453469.0,"shares_owned_after_display":"453,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-25","filed_date":"2018-09-27","scope":"insider","n_lines":2},{"id":6164936,"accession":"0001437749-18-016812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-18-016812","line_url":"/filing/0001437749-18-016812#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":14.95,"price_display":"14.95","price_state":"stated","total_value":598000.0,"total_display":"598,000.00","total_whole":"598,000","shares_owned_after":485296.0,"shares_owned_after_display":"485,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-07","filed_date":"2018-09-10","scope":"insider"},{"id":4799885,"accession":"0001437749-17-016781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-17-016781","line_url":"/filing/0001437749-17-016781#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":16.7806,"price_display":"16.78","price_state":"stated","total_value":922933.0,"total_display":"922,933.00","total_whole":"922,933","shares_owned_after":461668.0,"shares_owned_after_display":"461,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":4351027,"accession":"0001437749-17-012415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-17-012415","line_url":"/filing/0001437749-17-012415#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27168.0,"shares_display":"27,168","price_per_share":15.9381,"price_display":"15.94","price_state":"stated","total_value":433006.3008,"total_display":"433,006.30","total_whole":"433,006","shares_owned_after":461668.0,"shares_owned_after_display":"461,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-06","filed_date":"2017-07-10","scope":"insider"},{"id":4351017,"accession":"0001437749-17-012379","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-17-012379","line_url":"/filing/0001437749-17-012379","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32832.0,"shares_display":"32,832","price_per_share":16.5822,"price_display":"16.58","price_state":"stated","total_value":544426.7904,"total_display":"544,426.79","total_whole":"544,427","shares_owned_after":461668.0,"shares_owned_after_display":"461,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-07","scope":"insider","n_lines":2},{"id":5046111,"accession":"0001437749-17-012011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-17-012011","line_url":"/filing/0001437749-17-012011#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":16.0599,"price_display":"16.06","price_state":"stated","total_value":481797.0,"total_display":"481,797.00","total_whole":"481,797","shares_owned_after":461668.0,"shares_owned_after_display":"461,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-28","filed_date":"2017-06-29","scope":"insider"},{"id":5003291,"accession":"0001437749-17-006144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-17-006144","line_url":"/filing/0001437749-17-006144#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":15.4335,"price_display":"15.43","price_state":"stated","total_value":463005.0,"total_display":"463,005.00","total_whole":"463,005","shares_owned_after":461668.0,"shares_owned_after_display":"461,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-05","scope":"insider"},{"id":4584689,"accession":"0001437749-17-001875","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-17-001875","line_url":"/filing/0001437749-17-001875#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":13.355,"price_display":"13.36","price_state":"stated","total_value":333875.0,"total_display":"333,875.00","total_whole":"333,875","shares_owned_after":438495.0,"shares_owned_after_display":"438,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-07","scope":"insider"},{"id":3024712,"accession":"0001437749-16-043586","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-16-043586","line_url":"/filing/0001437749-16-043586#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7052.0,"shares_display":"7,052","price_per_share":15.0654,"price_display":"15.07","price_state":"stated","total_value":106241.2008,"total_display":"106,241.20","total_whole":"106,241","shares_owned_after":443314.0,"shares_owned_after_display":"443,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-20","scope":"insider"},{"id":3364849,"accession":"0001437749-16-043049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-16-043049","line_url":"/filing/0001437749-16-043049#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1140.0,"shares_display":"1,140","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":17100.0,"total_display":"17,100.00","total_whole":"17,100","shares_owned_after":443314.0,"shares_owned_after_display":"443,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-05","filed_date":"2016-12-07","scope":"insider"},{"id":2976412,"accession":"0001437749-16-042923","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-16-042923","line_url":"/filing/0001437749-16-042923#line-4","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":443314.0,"shares_owned_after_display":"443,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-02","filed_date":"2016-12-05","scope":"insider"},{"id":2976402,"accession":"0001437749-16-042923","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-16-042923","line_url":"/filing/0001437749-16-042923#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592286","owner_name":"Wrighton-Smith Peter","owner_display_name":"Wrighton-Smith Peter","owner_url":"/insider/0001592286","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60808.0,"shares_display":"60,808","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":912120.0,"total_display":"912,120.00","total_whole":"912,120","shares_owned_after":443314.0,"shares_owned_after_display":"443,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001586049","name":"Oxford Immunotec Global PLC","url":"/issuer/0001586049","role":"Director, Officer (Chief Executive Officer)","n_filings":19,"first_seen":"2016-12-05","last_seen":"2020-05-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001592286","retrieved_at":"2026-08-25T09:57:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}